跳到正文

van Houte Hans 内部人交易:近期 SEC Form 4 交易

过去 18 个月,van Houte Hans(CIK 1817217)在 1 家公司共报告 36 笔 SEC Form 4 内部人交易(最近一笔 2026-11-04)。

日期公司身份类型股数市值
2026-11-04Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出3,300$50,762
2026-11-04Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出1,469$23,800
2026-11-02Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,750$0
2026-11-02Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,859$0
2026-11-02Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,573$0
2026-11-02Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出2,834$74,475
2026-08-04Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出1,794$42,859
2026-08-04Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出2,967$73,137
2026-07-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,750$0
2026-07-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,858$0
2026-07-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,572$0
2026-07-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出2,845$66,516
2026-05-05Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出13,473$223,382
2026-05-05Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出582$9,999
2026-04-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,000$0
2026-04-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,750$0
2026-04-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,858$0
2026-04-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出2,388$39,760
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,887$0
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,000$0
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入3,750$0
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer买入2,859$0
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出3,588$59,489
2026-01-30Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出73$1,268
2025-11-03Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer卖出6,284$78,927

来源:SEC Form 4 申报文件 · 截至 2026-11-04